How are Norgestimate And Ethinyl Estradiol adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Norgestimate And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Norgestimate And Ethinyl Estradiol is flagged as the suspect drug causing the adverse event.
What are the most common Norgestimate And Ethinyl Estradiol adverse events reported to the FDA?
Pregnancy On Oral Contraceptive | 103 (11.84%) |
Drug Ineffective | 62 (7.13%) |
Product Quality Issue | 48 (5.52%) |
Drug Interaction | 28 (3.22%) |
Off Label Use | 22 (2.53%) |
Drug Exposure During Pregnancy | 18 (2.07%) |
Metrorrhagia | 18 (2.07%) |
Cerebrovascular Accident | 16 (1.84%) |
Nausea | 12 (1.38%) |
Anxiety | 11 (1.26%) |
Headache | 11 (1.26%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Norgestimate And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norgestimate And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Norgestimate And Ethinyl Estradiol adverse events reported to the FDA?
Pregnancy, Labour, Delivery And Pos... | 123 (14.14%) |
Therapeutic And Nontherapeutic Effe... | 96 (11.03%) |
Product Quality Issues | 52 (5.98%) |
Gastrointestinal Signs | 43 (4.94%) |
Menstrual Cycle And Uterine Bleedin... | 43 (4.94%) |
Central Nervous System Vascular | 23 (2.64%) |
Embolism And Thrombosis | 23 (2.64%) |
Therapeutic Procedures And Supporti... | 23 (2.64%) |
Chemical Injury And Poisoning | 22 (2.53%) |
Epidermal And Dermal Conditions | 20 (2.3%) |
Neurological | 17 (1.95%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Norgestimate And Ethinyl Estradiol, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Norgestimate And Ethinyl Estradiol is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Norgestimate And Ethinyl Estradiol, according to those reporting adverse events to the FDA?
Contraception | 240 |
Oral Contraception | 38 |
Product Used For Unknown Indication | 29 |
Drug Use For Unknown Indication | 23 |
Menstruation Irregular | 10 |
Acne | 9 |
Show More |
Label | Labeler | Effective |
---|---|---|
Mononessa | Watson Pharmaceuticals | 07-DEC-10 |
Trinessa | Watson Pharmaceuticals | 07-DEC-10 |
Ortho Tri Cyclen Lo | Physicians Total Care, Inc. | 03-FEB-11 |
Tri-sprintec | MedVantx, Inc. | 03-AUG-11 |
Tri-sprintec | Rebel Distributors Corp | 06-SEP-11 |
Trinessa | Rebel Distributors Corp | 13-SEP-11 |
Ortho Tri Cyclen | Physicians Total Care, Inc. | 27-FEB-12 |
Norgestimate And Ethinyl Estradiol | Glenmark Generics Inc., USA | 13-APR-12 |
Norgestimate And Ethinyl Estradiol | Glenmark Generics Inc., USA | 17-APR-12 |
Tri-sprintec | Physicians Total Care, Inc. | 19-APR-12 |
Trinessa | Physicians Total Care, Inc. | 23-MAY-12 |
Tri-lo-sprintec | Teva Pharmaceuticals USA Inc | 03-JUL-12 |
Estarylla | Sandoz Inc | 05-JUL-12 |
Tri-estarylla | Sandoz Inc | 06-JUL-12 |
Mono-linyah | Northstar Rx LLC | 01-AUG-12 |
Tri-sprintec | Barr Laboratories Inc. | 07-AUG-12 |
Tri Previfem | Qualitest Pharmaceuticals | 24-AUG-12 |
Previfem | Qualitest Pharmaceuticals | 24-AUG-12 |
Tri-linyah | Northstar Rx LLC | 01-SEP-12 |
Ortho Tri Cyclen Lo | Janssen Pharmaceuticals, Inc. | 04-MAR-13 |
Ortho Tri Cyclen | Janssen Pharmaceuticals, Inc. | 08-MAR-13 |
Ortho Cyclen | Janssen Pharmaceuticals, Inc. | 08-MAR-13 |
What Norgestimate And Ethinyl Estradiol safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Norgestimate And Ethinyl Estradiol. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Norgestimate And Ethinyl Estradiol.